Miami University Researchers Collaborate with PsyBio Therapeutics to Biosynthetically Produce Psilocybin, the Psychedelic Ingredient in Magic Mushrooms, and Other Psychoactive Drug Candidates to Treat Mental Health Challenges
May 22, 2020 08:30 ET
|
PsyBio Therapeutics Inc.
OXFORD, Ohio, May 22, 2020 (GLOBE NEWSWIRE) -- via NetworkWire – Miami University in Oxford, Ohio, and PsyBio Therapeutics Inc. (“PsyBio”) www.psybiolife.com are collaborating to develop a new and...
INmune Bio Initiates Phase I Clinical Trial of INB03
May 23, 2018 08:30 ET
|
INmune Bio, Inc.
LA JOLLA, Calif., May 23, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – INmune Bio, Inc., an immunotherapy company developing therapies that reprogram the patient’s innate immune system to treat...